Replies to post #158534 on Biotech Values

[DewDiligence]

XOMA—It’s odd to hire a CCO so far in advance of potential commercialization, although the stated rationale in yesterday’s PR (#msg-85810796) of obtaining market research to guide clinical development makes some sense.

p.s. Welcome to the board!

p.p.s. I commented on the acne-dosing issue in #msg-85641206.

[BTH]

Assuming positive Phase 3 in XOMA, where does this go (stock price) (assuming good environment for equities)?

I am long. I try to stay in oncology, but bought this one because it sounded interesting.
Thanks.